Huaren Pharmaceutical Co Stock | 300110.SZ | CNE100000SW1 |

Date	Huaren Pharmaceutical Co Price
2/13/2025	3.22 undefined
2/12/2025	3.26 undefined
2/11/2025	3.28 undefined
2/10/2025	3.34 undefined
2/7/2025	3.25 undefined
2/6/2025	3.19 undefined
2/5/2025	3.16 undefined
1/27/2025	3.09 undefined
1/24/2025	3.36 undefined
1/23/2025	3.35 undefined
1/22/2025	3.34 undefined
1/21/2025	3.38 undefined
1/20/2025	3.42 undefined
1/17/2025	3.38 undefined
1/16/2025	3.40 undefined

Date	Huaren Pharmaceutical Co Revenue	Huaren Pharmaceutical Co EBIT	Huaren Pharmaceutical Co Net Income
2023	1.64 B undefined	286.11 M undefined	188.06 M undefined
2022	1.62 B undefined	251.97 M undefined	180.82 M undefined
2021	1.56 B undefined	213.47 M undefined	130.4 M undefined
2020	1.62 B undefined	121 M undefined	94.6 M undefined
2019	1.46 B undefined	97.6 M undefined	42.1 M undefined
2018	1.38 B undefined	74 M undefined	38.8 M undefined
2017	1.31 B undefined	100.5 M undefined	37.5 M undefined
2016	1.25 B undefined	82.6 M undefined	23.9 M undefined
2015	1.11 B undefined	80.2 M undefined	22.9 M undefined
2014	916.8 M undefined	102.2 M undefined	56.2 M undefined
2013	867.2 M undefined	164.3 M undefined	121.5 M undefined
2012	562 M undefined	116.1 M undefined	96.6 M undefined
2011	405.3 M undefined	89.3 M undefined	87.6 M undefined
2010	338.3 M undefined	93.8 M undefined	76.3 M undefined
2009	288.5 M undefined	87 M undefined	60.8 M undefined
2008	207.6 M undefined	62.7 M undefined	46.4 M undefined
2007	161.1 M undefined	45.7 M undefined	34.1 M undefined

	Revenue	EBIT	Net Income
2007	161.1 M CNY	45.7 M CNY	34.1 M CNY
2008	207.6 M CNY	62.7 M CNY	46.4 M CNY
2009	288.5 M CNY	87 M CNY	60.8 M CNY
2010	338.3 M CNY	93.8 M CNY	76.3 M CNY
2011	405.3 M CNY	89.3 M CNY	87.6 M CNY
2012	562 M CNY	116.1 M CNY	96.6 M CNY
2013	867.2 M CNY	164.3 M CNY	121.5 M CNY
2014	916.8 M CNY	102.2 M CNY	56.2 M CNY
2015	1.11 B CNY	80.2 M CNY	22.9 M CNY
2016	1.25 B CNY	82.6 M CNY	23.9 M CNY
2017	1.31 B CNY	100.5 M CNY	37.5 M CNY
2018	1.38 B CNY	74 M CNY	38.8 M CNY
2019	1.46 B CNY	97.6 M CNY	42.1 M CNY
2020	1.62 B CNY	121 M CNY	94.6 M CNY
2021	1.56 B CNY	213.47 M CNY	130.4 M CNY
2022	1.62 B CNY	251.97 M CNY	180.82 M CNY
2023	1.64 B CNY	286.11 M CNY	188.06 M CNY

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.16	0.21	0.29	0.34	0.41	0.56	0.87	0.92	1.11	1.25	1.31	1.38	1.46	1.62	1.56	1.62	1.64
-	28.57	39.13	17.36	19.82	38.77	54.27	5.65	20.63	13.03	4.96	5.49	5.64	10.61	-3.47	3.78	1.05
44.10	51.69	56.25	55.33	55.06	56.05	52.94	47.93	44.34	44.60	52.94	57.41	56.13	34.28	48.72	42.93	42.48
71	107	162	187	223	315	459	439	490	557	694	794	820	554	760	695	695
34	46	60	76	87	96	121	56	22	23	37	38	42	94	130	180	188
-	35.29	30.43	26.67	14.47	10.34	26.04	-53.72	-60.71	4.55	60.87	2.70	10.53	123.81	38.30	38.46	4.44
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.77	0.77	0.79	0.92	1.1	1.13	1.16	1.14	1.13	1.13	1.13	1.15	1.18	1.18	1.18	1.18	1.18
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022	2023

13.4	48.6	27.8	471.3	305.8	120.7	362.9	204.9	144.8	30.2	148	617.2	358.8	219.6	417.15	222.63	144.13	231.87
85.7	103.4	132.2	136.8	183.5	248.9	402.1	492.6	594	601.6	625.2	583.5	549.4	862.7	887.34	802.99	636.69	654.73
0.03	0.01	0.02	0.06	0.07	0.1	0.09	0.14	0.13	0.17	0.24	0.2	0.16	0.13	1.42	1.52	1.54	1.53
24.5	27.1	48.3	50.2	47.8	87.9	118	185.2	212.5	186.9	198.4	195.1	193.2	259	275.47	275.47	266.85	334.63
8.7	13.9	44.3	18.2	43.2	27.5	25.6	41.8	67.6	51	63.8	37.5	51.4	125.7	201.36	286.62	140.47	38.76
0.16	0.2	0.27	0.74	0.65	0.58	1	1.06	1.15	1.04	1.27	1.63	1.32	1.6	3.2	3.11	2.73	2.79
0.18	0.29	0.35	0.37	0.55	1.04	1.19	1.38	1.38	1.45	1.37	1.29	1.19	1.3	1.22	1.24	1.16	1.14
0	0	0	0	0	30	30	0.4	0	0	6	23.7	0	16	16.58	25.95	25.66	25.37
0	0	0	0	0	0	0	0	0	0	0.02	0	0	0	1.42	0	1.43	0
17.7	17	17.1	46.9	50.7	102	112.3	111.8	112.8	123.1	118.8	122.3	117.5	156.9	366.16	371	344.31	331.57
0	0	0	0	0	21.9	28.2	31.9	33.5	33.5	28.2	28.2	28.2	283.6	826.64	826.64	826.29	820.04
1.1	1	1.2	1.3	5.6	10.2	10.1	36.2	69.1	75.4	68.2	57.1	60.7	65.5	36.58	67.51	74.52	61.44
0.2	0.31	0.36	0.42	0.6	1.2	1.37	1.56	1.6	1.68	1.61	1.52	1.39	1.82	3.88	2.53	3.86	2.37
0.36	0.51	0.64	1.15	1.25	1.79	2.37	2.62	2.75	2.73	2.89	3.15	2.71	3.42	7.08	5.64	6.59	5.17

0.15	0.15	0.16	0.21	0.21	0.22	0.45	0.67	0.66	0.66	0.99	1.18	1.18	1.18	1.18	1.18	1.18	1.18
10	0	22	682.4	682.4	719.1	539.9	345.9	323.9	310.8	47.9	528	528	528	528.04	528.04	528.04	528.04
24.7	71	131.8	208.1	295.7	349.6	471.1	482.4	472.5	496.4	451.5	470.5	465.6	548.4	661.09	661.09	820.63	983.83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	72.09	0	68.88	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.18	0.22	0.31	1.1	1.19	1.29	1.46	1.5	1.46	1.46	1.49	2.18	2.18	2.26	2.44	2.37	2.6	2.69
13.2	21.5	19.3	16.6	22.2	160.2	128.8	133.5	121	116.9	113.2	103.5	106.8	137.9	127.08	127.08	122.75	142.32
1.4	2.5	2.1	0	0.1	11.6	19.6	11.4	17	19.1	22.1	22.2	28.2	116.6	183.32	187.89	211.02	198.3
14.5	9	30.6	31	23.5	31.5	72.9	48.3	74.1	151.5	205.3	47.3	119.1	265	670.69	300.19	370.43	444.66
0.15	0.17	0.19	0	0	0.21	0.66	0.92	1.05	0.73	0.79	0.66	0.16	0.54	1.58	1.94	1.23	0.63
0	0	20	0	0	0	0	5.2	9.3	18	27.7	16.8	16.8	0	30.82	30.82	100.04	102.39
0.18	0.21	0.26	0.05	0.05	0.41	0.88	1.12	1.27	1.04	1.16	0.85	0.43	1.06	2.59	2.59	2.03	1.52
0	80	60	0	0	15	15	7.4	30	152.7	168.6	42	25.2	0	230.62	230.62	353.15	836.58
0	0	0	0	0	7.4	7.1	6.3	5.6	4.8	4.3	4.2	4	25.1	55.87	55.87	50.59	46.72
1	0.4	0	0	10	10	8	7.1	6	5	4	3	2	5.5	-1,330.02	320.89	129.58	0.18
1	80.4	60	0	10	32.4	30.1	20.8	41.6	162.5	176.9	49.2	31.2	30.6	-1,043.53	607.38	533.32	883.48
0.18	0.29	0.32	0.05	0.06	0.45	0.91	1.14	1.31	1.2	1.34	0.9	0.46	1.09	1.55	3.2	2.56	2.4
0.36	0.51	0.64	1.15	1.25	1.73	2.37	2.64	2.77	2.66	2.82	3.08	2.64	3.34	3.99	5.57	5.16	5.09

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	130	0	180
0	0	0	0	0	0	0	0	0	0	0	0	0	0	144	0	148
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-9	0	-15
-11	-25	-64	-53	-67	-205	-335	-407	-495	-436	-473	-463	-429	-281	-1,014	-1,169	-580
0	0	0	0	0	0	0	0	0	0	0	0	0	0	154	0	108
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-21	-38	-35	-59	-64	-74	-108	-123	-147	-144	-153	-178	-154	-162	183	-183	-146
7	57	38	77	59	99	39	65	18	181	211	254	309	-10	-578	-578	217
-8	-130	-100	-67	-232	-270	-227	-259	-156	-169	-87	-45	-32	-58	-27	-27	-42
-8	-140	-100	-66	-222	-353	-285	-228	-156	-168	-95	-55	5	-238	-458	-458	-143
0	-9	0	0	10	-82	-58	31	0	0	-8	-9	37	-180	-430	-430	-101
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.02	0.11	0.02	-0.27	0	0.1	0.44	0.18	0.19	-0.27	0.06	-0.11	-0.52	0.16	1.3	1.3	-0.17
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0.12	0.04	0.43	-0	0.07	0.49	0	0.08	-0.13	0	0.27	-0.58	0.11	1.04	1.04	-0.15
-7	15	32	715	0	-24	71	-86	-21	189	-8	436	-2	-22	-189	-189	105
-9	-11	-12	-12	-2	-7	-23	-87	-87	-50	-49	-55	-58	-22	-71	-71	-89
0.04	0.16	0.12	0.63	0.03	0.19	0.73	0.44	0.6	0.65	0.96	1.37	0.63	0.3	0.78	0.78	0.87
-1.2	-73.6	-62.1	10.5	-173.3	-171	-187.9	-194.2	-137.9	12.7	123.7	208.8	277.3	-68.7	-606.38	-606.38	175.65
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Huaren Pharmaceutical Co Gross margin	Huaren Pharmaceutical Co Profit margin	Huaren Pharmaceutical Co EBIT margin	Huaren Pharmaceutical Co Profit margin
2023	42.53 %	17.49 %	11.49 %
2022	42.97 %	15.56 %	11.16 %
2021	48.7 %	13.68 %	8.35 %
2020	34.31 %	7.49 %	5.85 %
2019	56.11 %	6.68 %	2.88 %
2018	57.37 %	5.35 %	2.8 %
2017	52.91 %	7.66 %	2.86 %
2016	44.65 %	6.61 %	1.91 %
2015	44.39 %	7.25 %	2.07 %
2014	47.89 %	11.15 %	6.13 %
2013	53 %	18.95 %	14.01 %
2012	56.16 %	20.66 %	17.19 %
2011	55.24 %	22.03 %	21.61 %
2010	55.42 %	27.73 %	22.55 %
2009	56.29 %	30.16 %	21.07 %
2008	51.88 %	30.2 %	22.35 %
2007	44.63 %	28.37 %	21.17 %

	Gross margin	EBIT margin	Profit margin
2007	44.63 %	28.37 %	21.17 %
2008	51.88 %	30.2 %	22.35 %
2009	56.29 %	30.16 %	21.07 %
2010	55.42 %	27.73 %	22.55 %
2011	55.24 %	22.03 %	21.61 %
2012	56.16 %	20.66 %	17.19 %
2013	53 %	18.95 %	14.01 %
2014	47.89 %	11.15 %	6.13 %
2015	44.39 %	7.25 %	2.07 %
2016	44.65 %	6.61 %	1.91 %
2017	52.91 %	7.66 %	2.86 %
2018	57.37 %	5.35 %	2.8 %
2019	56.11 %	6.68 %	2.88 %
2020	34.31 %	7.49 %	5.85 %
2021	48.7 %	13.68 %	8.35 %
2022	42.97 %	15.56 %	11.16 %
2023	42.53 %	17.49 %	11.49 %

Date	Huaren Pharmaceutical Co Sales per Share	Huaren Pharmaceutical Co EBIT per share	Huaren Pharmaceutical Co Earnings per Share
2023	1.38 undefined	0.24 undefined	0.16 undefined
2022	1.37 undefined	0.21 undefined	0.15 undefined
2021	1.32 undefined	0.18 undefined	0.11 undefined
2020	1.37 undefined	0.1 undefined	0.08 undefined
2019	1.24 undefined	0.08 undefined	0.04 undefined
2018	1.2 undefined	0.06 undefined	0.03 undefined
2017	1.16 undefined	0.09 undefined	0.03 undefined
2016	1.1 undefined	0.07 undefined	0.02 undefined
2015	0.98 undefined	0.07 undefined	0.02 undefined
2014	0.8 undefined	0.09 undefined	0.05 undefined
2013	0.75 undefined	0.14 undefined	0.1 undefined
2012	0.5 undefined	0.1 undefined	0.09 undefined
2011	0.37 undefined	0.08 undefined	0.08 undefined
2010	0.37 undefined	0.1 undefined	0.08 undefined
2009	0.37 undefined	0.11 undefined	0.08 undefined
2008	0.27 undefined	0.08 undefined	0.06 undefined
2007	0.21 undefined	0.06 undefined	0.04 undefined

	Sales per Share	EBIT per share	Earnings per Share
2007	0.21 CNY	0.06 CNY	0.04 CNY
2008	0.27 CNY	0.08 CNY	0.06 CNY
2009	0.37 CNY	0.11 CNY	0.08 CNY
2010	0.37 CNY	0.1 CNY	0.08 CNY
2011	0.37 CNY	0.08 CNY	0.08 CNY
2012	0.5 CNY	0.1 CNY	0.09 CNY
2013	0.75 CNY	0.14 CNY	0.1 CNY
2014	0.8 CNY	0.09 CNY	0.05 CNY
2015	0.98 CNY	0.07 CNY	0.02 CNY
2016	1.1 CNY	0.07 CNY	0.02 CNY
2017	1.16 CNY	0.09 CNY	0.03 CNY
2018	1.2 CNY	0.06 CNY	0.03 CNY
2019	1.24 CNY	0.08 CNY	0.04 CNY
2020	1.37 CNY	0.1 CNY	0.08 CNY
2021	1.32 CNY	0.18 CNY	0.11 CNY
2022	1.37 CNY	0.21 CNY	0.15 CNY
2023	1.38 CNY	0.24 CNY	0.16 CNY

	Number of stocks
2007	774.5 M Aktien
2008	774.5 M Aktien
2009	787.4 M Aktien
2010	918.4 M Aktien
2011	1.1 B Aktien
2012	1.13 B Aktien
2013	1.16 B Aktien
2014	1.14 B Aktien
2015	1.13 B Aktien
2016	1.13 B Aktien
2017	1.13 B Aktien
2018	1.15 B Aktien
2019	1.18 B Aktien
2020	1.18 B Aktien
2021	1.18 B Aktien
2022	1.18 B Aktien
2023	1.18 B Aktien

Date	Huaren Pharmaceutical Co Payout ratio
2023	12.62 %
2022	11.77 %
2021	13.6 %
2020	12.5 %
2019	75 %
2018	55.61 %
2017	49.38 %
2016	12.62 %
2015	230 %
2014	121.2 %
2013	12.62 %
2012	67.33 %
2011	12.62 %
2010	12.62 %
2009	12.62 %
2008	12.62 %
2007	12.62 %

	Payout ratio
2007	12.62 %
2008	12.62 %
2009	12.62 %
2010	12.62 %
2011	12.62 %
2012	67.33 %
2013	12.62 %
2014	121.2 %
2015	230 %
2016	12.62 %
2017	49.38 %
2018	55.61 %
2019	75 %
2020	12.5 %
2021	13.6 %
2022	11.77 %
2023	12.62 %

Date	EPS Estimate	EPS Actual	Quarterly report
12/31/2016	0.01	0.01 (-5.64 %)	2016 Q4
9/30/2016	0	0.01 (0 %)	2016 Q3
6/30/2016	0	0 (0 %)	2016 Q2
12/31/2015	0.01	-0.01 (-296.95 %)	2015 Q4
9/30/2015	0.04	0.01 (-85.86 %)	2015 Q3
6/30/2015	0.06	0.01 (-90.1 %)	2015 Q2
12/31/2014	0.07	0.01 (-88.45 %)	2014 Q4
9/30/2014	0.07	0.02 (-68.81 %)	2014 Q3
6/30/2014	0.04	-0.01 (-119.78 %)	2014 Q2
12/31/2013	0.16	0.03 (-78.27 %)	2013 Q4
9/30/2013	0.12	0.03 (-73.6 %)	2013 Q3
6/30/2013	0.09	0 (-95.83 %)	2013 Q2

%	Name	Stocks	Change	Date
20.00005 %	Xi'an Qujiang Tianshou Big Health Investment Partnership (LP)	236,442,597	0	6/30/2024
7.89750 %	Huaren Century Group Co., Ltd.	93,365,046	2,976,180	6/30/2024
7.22968 %	Hongta Innovation Investment Co., Ltd.	85,470,000	-5,793,000	9/20/2024
4.86344 %	Yongyu Hengfeng Investment Management Co., Ltd.	57,496,123	0	6/30/2024
1.99998 %	Lu (Bo)	23,644,000	0	6/30/2024
1.11446 %	Qi (Junshu)	13,175,278	-1,084,800	6/30/2024
0.86803 %	Wu (Yuan)	10,261,900	0	6/30/2024
0.72059 %	Liu (Meihua)	8,518,900	0	6/30/2024
0.64286 %	Zhao (Xiang Dong)	7,600,000	0	6/30/2024
0.15472 %	The Vanguard Group, Inc.	1,829,072	-720,300	9/30/2024
0.11166 %	Yang (Xiaodong)	1,320,000	0	6/30/2024
0.03290 %	Huatai-PineBridge Fund Management Co., Ltd.	388,900	108,400	6/30/2024
0.03224 %	Truvalue Asset Management Co., Ltd.	381,200	381,200	6/30/2024
0.02478 %	GF Fund Management Co., Ltd.	293,000	-274,200	6/30/2024
0.01641 %	Bosera Asset Management Co., Ltd.	194,000	0	6/30/2024
0.01386 %	Harvest Fund Management Co., Ltd.	163,800	153,400	6/30/2024
0.00898 %	SWS MU Fund Management Co., Ltd.	106,200	96,900	6/30/2024
0.00549 %	Sealand Securities Co., Ltd.	64,940	-6,460	6/30/2024
0.00512 %	Wang (Junhong)	60,500	0	12/31/2023
0.00483 %	Rongtong Fund Management Co., Ltd.	57,100	57,100	6/30/2024
0.00392 %	INVESCO Great Wall Fund Management Co. Ltd.	46,400	-128,400	6/30/2024
0.00341 %	E Fund Management Co. Ltd.	40,300	24,200	6/30/2024
0.00240 %	Penghua Fund Management Co., Ltd.	28,400	-78,000	6/30/2024
0.00198 %	Hwabao WP Fund Management Co., Ltd.	23,400	23,400	6/30/2024
0.00174 %	Minsheng Royal Fund Management Company Ltd.	20,600	20,600	6/30/2024
0.00169 %	China Universal Asset Management Co., Ltd.	20,000	20,000	12/31/2023
0.00106 %	Yinhua Fund Management Co., Ltd.	12,500	12,500	6/30/2024
0.00084 %	China Southern Asset Management Co. Ltd.	9,900	9,900	12/31/2023
0.00082 %	Vanguard Investments Australia Ltd.	9,750	-60	6/30/2024
0.00065 %	China Asset Management Co., Ltd.	7,700	-14,600	6/30/2024
0.00029 %	Xingyin Fund Management Co., Ltd.	3,400	3,400	6/30/2024
0.00025 %	Guotai Asset Management Co., Ltd.	2,900	2,900	12/31/2023
0.00005 %	Bank of Beijing Scotiabank Asset Management Co., Ltd.	600	600	6/30/2024
0 %	Guotai Junan Securities Assets Management Co., Ltd.	0	-43,300	6/30/2024
0 %	ABC-CA Fund Management Co., Ltd.	0	-47,400	6/30/2024
0 %	Taikang Asset Management Co., Ltd.	0	-120,200	12/31/2023
0 %	Tianhong Asset Management Co., Ltd.	0	-104,400	6/30/2024
0 %	Morgan Stanley Investment Management (China) Company Limited.	0	-851,700	6/30/2024
0 %	Lion Fund Management Co., Ltd.	0	-8,900	12/31/2023
0 %	Wanjia Asset Management Co., Ltd.	0	-697,400	12/31/2023
0 %	Manulife Fund Management Co., Ltd.	0	-6,800	6/30/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Xinyaqiang Silicon Chemistry A	SupplierCustomer	0,24	0,11	0,62	0,54	0,14
Shenzhen Neptunus H	SupplierCustomer	-0,01	0,24	0,13		0,16	0,69
Moon Environment Tech A	SupplierCustomer	-0,32	0,55	0,83	0,75	0,44	-0,25
Xinlun New Materials A	SupplierCustomer	-0,80	0,08	0,81	0,61	0,44	0,01

What values and corporate philosophy does Huaren Pharmaceutical Co represent?

Huaren Pharmaceutical Co Ltd represents a commitment to providing high-quality healthcare products and services. With a focus on innovation and research, the company aims to contribute to the wellbeing of society. Their corporate philosophy emphasizes integrity, responsibility, and sustainability. Huaren Pharmaceutical Co Ltd strives to deliver value to its customers through continuous improvement, customer-centricity, and a strong sense of social responsibility.

In which countries and regions is Huaren Pharmaceutical Co primarily present?

Huaren Pharmaceutical Co Ltd is primarily present in China, where the company is headquartered. As a leading pharmaceutical company in China, Huaren Pharmaceutical Co Ltd operates nationwide and has a strong presence in various regions across the country. With an extensive network of manufacturing facilities, research centers, and distribution channels, the company serves the local market and contributes to the healthcare sector in China.

What significant milestones has the company Huaren Pharmaceutical Co achieved?

Huaren Pharmaceutical Co Ltd has achieved several significant milestones. Over the years, the company has seen impressive growth and expansion in its operations. One of the key milestones is the successful development and launch of innovative pharmaceutical products, positioning them at the forefront of the industry. Additionally, Huaren Pharmaceutical has expanded its market reach, establishing a strong presence both domestically and internationally. With a commitment to research and development, the company has received numerous accolades and recognition for its contributions to the healthcare sector. As a trusted name in the industry, Huaren Pharmaceutical Co Ltd continues to strive for excellence and achieve new milestones in the field of pharmaceuticals.

What is the history and background of the company Huaren Pharmaceutical Co?

Huaren Pharmaceutical Co Ltd, a leading pharmaceutical company, has a rich history and impressive background. Established in [year], it has evolved into a renowned player in the industry. Huaren Pharmaceutical Co Ltd primarily focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products. With a commitment to innovation and quality, the company has established itself as a trusted provider of healthcare solutions worldwide. Over the years, Huaren Pharmaceutical Co Ltd has strengthened its research and development capabilities, consistently introducing new and effective medicines. Its dedication to improving global health has earned it a prominent position, making it an excellent choice for investors seeking a reliable and successful pharmaceutical company.

Who are the main competitors of Huaren Pharmaceutical Co in the market?

The main competitors of Huaren Pharmaceutical Co Ltd in the market include Jiangzhong Group Co Ltd, Tasly Pharmaceutical Group Co Ltd, and Beijing Tiantan Biological Products Co Ltd.

In which industries is Huaren Pharmaceutical Co primarily active?

Huaren Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Huaren Pharmaceutical Co?

The business model of Huaren Pharmaceutical Co Ltd focuses on the research, development, and manufacturing of pharmaceutical products. The company primarily engages in the production of traditional Chinese medicines and modern pharmaceuticals. Huaren Pharmaceutical Co Ltd actively participates in the entire value chain of the pharmaceutical industry, including drug discovery, clinical trials, production, and marketing. By emphasizing innovation and quality, the company aims to provide effective and safe healthcare solutions to its customers. Huaren Pharmaceutical Co Ltd's business model is centered on meeting the healthcare needs of individuals by offering a diverse range of high-quality pharmaceutical products.

What is the P/E ratio of Huaren Pharmaceutical Co 2025?

The P/E ratio cannot be calculated for Huaren Pharmaceutical Co at the moment.

What is the P/S ratio of Huaren Pharmaceutical Co 2025?

The P/S cannot be calculated for Huaren Pharmaceutical Co currently.

What is the Quality Investing of Huaren Pharmaceutical Co?

The Quality Investing for Huaren Pharmaceutical Co is 4/10.

What is the revenue of Huaren Pharmaceutical Co 2025?

The revenue cannot currently be calculated for Huaren Pharmaceutical Co.

How high is the profit of Huaren Pharmaceutical Co 2025?

The profit cannot currently be calculated for Huaren Pharmaceutical Co.

What is the business model of Huaren Pharmaceutical Co

Huaren Pharmaceutical Co. Ltd is a Chinese company specializing in the manufacturing and distribution of pharmaceutical products. It was founded in 1997 and is headquartered in Xi'an, Shaanxi province, China. The company's business model focuses on producing high-quality pharmaceutical products and distributing them worldwide. It manufactures both medicines and dietary supplements, using modern production methods and strict quality control to ensure its products meet the highest standards. Huaren Pharmaceutical's core sector is the production of traditional Chinese medicines, which are made from natural plant extracts and have been an important part of Chinese medicine for centuries. The company also produces modern medicines such as antibiotics, antiviral drugs, cardiovascular medications, and diabetes medications. Another important sector for Huaren Pharmaceutical is the production of dietary supplements that support nutrition and provide essential nutrients to the body. The company also creates products tailored to the needs of children, women, and older adults. Huaren Pharmaceutical aims to develop new technologies and treatment methods to improve its customers' health and well-being. It invests a significant amount of resources in research and development, with its own laboratories and research facilities for developing new medicines and dietary supplements. As part of its growth strategy, Huaren Pharmaceutical has expanded into the export market and has exported its products to various countries worldwide. It has established distribution offices and partners in Europe, North America, and Asia to strengthen its presence in the global market. In summary, Huaren Pharmaceutical Co. Ltd specializes in manufacturing and distributing pharmaceutical products. It produces traditional Chinese medicines, modern medicines, and dietary supplements. It invests heavily in research and development, continuously improving its products and developing new technologies. By exporting its products to different countries worldwide, the company has expanded its presence in the global market.

What is the Huaren Pharmaceutical Co dividend?

Huaren Pharmaceutical Co pays a dividend of 0.02 CNY distributed over payouts per year.

How often does Huaren Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for Huaren Pharmaceutical Co or the company does not pay out a dividend.

What is the Huaren Pharmaceutical Co ISIN?

The ISIN of Huaren Pharmaceutical Co is CNE100000SW1.

What is the Huaren Pharmaceutical Co ticker?

The ticker of Huaren Pharmaceutical Co is 300110.SZ.

How much dividend does Huaren Pharmaceutical Co pay?

Over the past 12 months, Huaren Pharmaceutical Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, Huaren Pharmaceutical Co is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Huaren Pharmaceutical Co?

The current dividend yield of Huaren Pharmaceutical Co is 0.65 %.

When does Huaren Pharmaceutical Co pay dividends?

Huaren Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, August, August.

How secure is the dividend of Huaren Pharmaceutical Co?

Huaren Pharmaceutical Co paid dividends every year for the past 7 years.

What is the dividend of Huaren Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 0.65 %.

In which sector is Huaren Pharmaceutical Co located?

Huaren Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huaren Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huaren Pharmaceutical Co from 7/10/2024 amounting to 0.021 CNY, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did Huaren Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Huaren Pharmaceutical Co in the year 2024?

In the year 2024, Huaren Pharmaceutical Co distributed 0.018 CNY as dividends.

In which currency does Huaren Pharmaceutical Co pay out the dividend?

The dividends of Huaren Pharmaceutical Co are distributed in CNY.

Huaren Pharmaceutical Co Ticker	Huaren Pharmaceutical Co FIGI
300110:CH	BBG000DZ8G30
300110:CS	BBG000DZ8HS1
300110:C2	BBG00F139P03

Access the world's leading financial data and tools

Price

Price

Ticker300110.SZ

ISINCNE100000SW1

Huaren Pharmaceutical Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Huaren Pharmaceutical Co Stock Price History

Huaren Pharmaceutical Co Revenue, EBIT, Net Income CNE100000SW1 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Huaren Pharmaceutical Co Revenue, EBIT and net profit per share

Huaren Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Huaren Pharmaceutical Co stock margins CNE100000SW1 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Huaren Pharmaceutical Co Margin History

Huaren Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share CNE100000SW1 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Huaren Pharmaceutical Co Revenue, EBIT and net profit per share

Huaren Pharmaceutical Co business model

Huaren Pharmaceutical Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Huaren Pharmaceutical Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Huaren Pharmaceutical Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Huaren Pharmaceutical Co shares outstanding CNE100000SW1 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Huaren Pharmaceutical Co stock splits

Huaren Pharmaceutical Co dividend payout ratio CNE100000SW1 ·

Payout ratio

What is Yearly Payout Ratio?

How to Interpret the Data

Using the Data for Investments

Huaren Pharmaceutical Co Payout Ratio History

Ticker
300110.SZ

ISIN
CNE100000SW1